TTPAL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.762400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.222000E-01
Normal-vs-Stage2
2.714400E-01
Normal-vs-Stage3
1.135360E-01
Normal-vs-Stage4
6.911000E-01
Stage1-vs-Stage2
9.183400E-01
Stage1-vs-Stage3
2.914500E-02
Stage1-vs-Stage4
2.600800E-01
Stage2-vs-Stage3
6.062000E-02
Stage2-vs-Stage4
5.317400E-01
Stage3-vs-Stage4
2.231900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.023000E-01
Normal-vs-AfricanAmerican
6.814600E-01
Normal-vs-Asian
4.669700E-02
Caucasian-vs-AfricanAmerican
5.682400E-01
Caucasian-vs-Asian
3.209800E-02
AfricanAmerican-vs-Asian
5.036100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.815200E-01
Normal-vs-Female
3.006600E-01
Male-vs-Female
9.925000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.930000E-01
Normal-vs-Age(41-60Yrs)
5.045800E-01
Normal-vs-Age(61-80Yrs)
1.881220E-01
Normal-vs-Age(81-100Yrs)
5.249600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.293400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.969900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.951800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.614160E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.887600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.874800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.148610E-01
Normal-vs-Daily Drinker
2.780600E-01
Normal-vs-Weekly Drinker
5.525400E-01
Normal-vs-Occasional Drinker
5.286600E-01
Normal-vs-Social Drinker
5.866400E-01
Non Drinker-vs-Daily Drinker
3.119800E-01
Non Drinker-vs-Weekly Drinker
1.329400E-01
Non Drinker-vs-Occasional Drinker
1.255870E-02
Non Drinker-vs-Social Drinker
4.771600E-02
Daily Drinker-vs-Weekly Drinker
5.204800E-01
Daily Drinker-vs-Occasional Drinker
1.577820E-01
Daily Drinker-vs-Social Drinker
3.002600E-01
Weekly Drinker-vs-Occasional Drinker
6.610600E-01
Weekly Drinker-vs-Social Drinker
7.890000E-01
Occasional Drinker-vs-Social Drinker
8.638600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.172400E-01
Normal-vs-Grade 2
8.470800E-01
Normal-vs-Grade 3
8.957200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.672800E-01
Grade 1-vs-Grade 3
1.232390E-01
Grade 1-vs-Grade 4
8.172400E-01
Grade 2-vs-Grade 3
1.766550E-01
Grade 2-vs-Grade 4
8.470800E-01
Grade 3-vs-Grade 4
8.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.094400E-01
Normal-vs-NonDiabetic
2.412000E-01
Diabetic-vs-NonDiabetic
4.983000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.422000E-01
Normal-vs-NoPancreatitis
2.590200E-01
Pancreatitis-vs-NoPancreatitis
6.131800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.546800E-01
Normal-vs-N1
3.039000E-01
N0-vs-N1
6.501600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.256600E-01
Normal-vs-TP53-NonMutant
3.825600E-01
TP53-Mutant-vs-TP53-NonMutant
1.822160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
